[1] Qiu H, Cao S, Xu R.Cancer incidence, mortality, and burden in China:a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020[J]. Cancer Commun,2021,41(10):1037-1048.DOI: 10.1002/cac2.12197.
[2] Sung H, Ferlay J, Siegel RL, et al.Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA: A Cancer Journal for Clinicians, 2021, 71(3):209-249.DOI: 10.3322/caac.21660.
[3] 曹菊芳. 应用互联网平台进行随访在日间化疗患者延续性护理中的效果及满意度分析[J].系统医学, 2021, 6(15):4.DOI:10.19368/j.cnki.2096-1782.2021.15.180.
[4] 韩聚强,郑丽娜,朱玲玲,等.北京市部分综合性“三甲”医院日间诊疗运营模式调研分析与思考[J].解放军预防医学杂志,2020, 38(11):17-19.DOI:10.13704/j.cnki.jyyx.2020.11.008.
[5] Khanijazani R, Molavitaleghani Y, Seyedin H,et al.Risk Assessment of drug management process in women surgery department of Qaem Educational Hospital(QEH) Using HFMEA Method (2013)[J].Iran J Pharm Res, 2015,14(2):495-504.DOI:10.22037/IJPR.2015.1650.
[6] Kuo RJ, Wu YH, Hsu TS.Integration of fuzzy set theory and TOPSIS into HFMEA to improve outpatient service for elderly patients in Taiwan[J]. J Chin Med Assoc, 2012, 75(7):341-348.
[7] 王丹,莫陶欣,李晨雄,等.日间化疗质量与安全评价指标体系构建研究[J].中国医院管理,2023,43(3):51-54.
[8] 周琴,刘馨,李然,等.全程化药学服务在我院日间化疗中心的应用[J].中国药房,2019, 30(12):5.
[9] Weber L, Schulze I, Jaehde U.Using Failure Mode and Effects Analysis to increase patient safety in cancer chemotherapy[J]. Res social Adm Pharm, 2021. DOI:10.1016/j.sapharm.2021.11.009.
[10] Joly-Mischlich T, Maltais S, Tétu A, et al.Application of the Failure Mode and Effects Analysis (FMEA) to identify vulnerabilities and opportunities for improvement prior to implementing a computerized prescription order entry (CPOE) system in a university hospital oncology clinic[J]. J Oncol Pharm Pract, 2023,29(1):88-95.DOI:10.1177/10781552211053253.
[11] Lin S, Wang N, Ren B, et al. Use of Failure Mode and Effects Analysis (FMEA) for risk analysis of drug use in patients with lung cancer[J]. Int J Environ Res Public Health.2022 Nov 22, 19(23):15428.DOI:10.3390/ijerph192315428.
[12] Feemster AA, Augustino M, Duncan R, et al.Use of failure modes and effects analysis to mitigate potential risks prior to implementation of an intravenous compounding technology[J]. Am J Health Syst Pharm, 2021,78(14):1323-1329.DOI: 10.1093/ajhp/zxab179.
[13] 张娟,黄蓓蓓,余天浩,等.基于医疗失效模式与效应分析模型的急性缺血性脑卒中患者院内急救流程优化[J].护理学报, 2020, 27(4):5.DOI:10.16460/j.issn1008-9969.2020.04.016.
[14] 刘坤,张雨晨,刘争,等.医疗失效模式与效应分析在身份识别用药错误预防中的应用探讨[J].护士进修杂志,2023,38(6):549-553.DOI:10.16821/j.cnki.hsjx.2023.06.013.
[15] 李娜,熊晓云,郑青玉,等.医疗失效模式与效应分析在规范护理工作流程中的应用进展[J].护理学报, 2023,30(11):36-40.DOI:10.16460/j.issn1008-9969.2023.11.036.
[16] 中国肿瘤日间诊疗协作组.中国恶性肿瘤日间诊疗专家共识(2022版)[J].中华肿瘤杂志,2022,44(4):307-320.DOI:10.3760/cma.j.cn112152-20220223-00123.